This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Poniard, Netlist: Early Volume Plays

NEW YORK ( TheStreet) -- Several stocks trading under $5 were poised to move on above-average volume during Wednesday's session.

Poniard Pharmaceuticals (PARD) rose by 18 cents, or 7.3%, to $2.66 in the premarket session one day after the company said current study data shows a combination of its drug candidate picoplatin and chemotherapy works about as well as a standard chemotherapy regimen as a treatment for colorectal cancer. On Monday, Poniard disclosed the failed phase III study of picoplatin in small cell lung cancer. The 50-day average daily volume for Poniard is 2.2 million, according to the Nasdaq.

China Sunergy (CSUN) jumped by 37 cents, or 8.8%, to $4.60 in the premarket session after the company reported third-quarter adjusted earnings of 19 cents a share, well ahead of the Thomson Reuters average estimate of 2 cents a share. Full-year shipments will be between 190 megawatts of solar cells to 200 MW, which is at the high end previous guidance range. The 50-day average daily volume for China Sunergy is 304,000, according to the Nasdaq.

Netlist (NLST - Get Report) gained 30 cents, or 7.3%, to $4.40 in the premarket session, continuing the recently rally sparked by the introduction of the company's HyperCloud product, the first 16-gigabyte, 2 vRank memory module for computer servers. The 50-day average daily volume for Netlist is 1.1 million, according to the Nasdaq.

Oncolytics Biotech (ONCY) plummeted by 55 cents, or 16%, to $2.88 in the premarket session after the company late Tuesday announced a unit offering. The number and the price of each unit, as well as the exercise price of each warrant, will be determined in the context of the market with final terms to be determined at the time of pricing, the company said. Oncolytics intends to use the net proceeds from the offering to fund its previously announced phase III combination Reolysin, a treatment for head and neck cancer. The 50-day average daily volume for Oncolytics is 218,000, according to the Nasdaq.

Boise (BZ) gave back 11 cents, or 2.2%, to $4.98 in the premarket session after the company late Tuesday said its secondary offering of 17 million shares of its common stock has been priced at $4.85 a share. The three-month average daily volume for Boise is 1.2 million, according to Yahoo! Finance.

-- Written by Robert Holmes in New York.

Check out all of Wednesday's high-volume, under-$5 stocks at the Dollar Store

Follow Robert Holmes on Twitter and become a fan of on Facebook.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BZ $0.00 0.00%
PARD $0.14 0.00%
CSUN $1.21 0.00%
NLST $0.40 0.00%
ONCY $0.44 0.00%


Chart of I:DJI
DOW 16,472.37 +200.36 1.23%
S&P 500 1,951.36 +27.54 1.43%
NASDAQ 4,707.7750 +80.6910 1.74%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs